occurs in has participant quality has disease treated with drug METFORMIN TOPOTECAN METRONIDAZOLE LOVASTATIN MITOXANTRONE HYDROCHLORIDE DOXORUBICIN GANCICLOVIR FLUDARABINE PHOSPHATE TENIPOSIDE PACLITAXEL PAROXETINE DOCETAXEL ZAFIRLUKAST TOPIRAMATE TOLCAPONE RITUXIMAB INFLIXIMAB LEFLUNOMIDE TRASTUZUMAB RABEPRAZOLE SIROLIMUS BEXAROTENE EMTRICITABINE DAPTOMYCIN ERLOTINIB MARAVIROC GOLIMUMAB CERTOLIZUMAB PEGOL mature T-cell and NK-cell lymphoma non-Hodgkin lymphoma Cytomegalovirus retinitis prostate cancer endocarditis lymphoblastic leukemia chronic lymphocytic leukemia lung cancer generalized anxiety disorder Parkinson's disease breast cancer pancreatic cancer epilepsy arteriosclerotic cardiovascular disease ovarian cancer asthma lymphangioleiomyomatosis bacterial vaginosis cervical cancer human immunodeficiency virus infectious disease ankylosing spondylitis rheumatoid arthritis gastroesophageal reflux disease ulcerative colitis Crohn's disease psoriasis psoriatic arthritis acute myeloid leukemia type 2 diabetes mellitus Elderly Child Adult Adolescent adverse event infection AE 10021789 infectious adverse event YH, JX infection an adverse event that has an outcome of a pathogen infection, i.e., an infection caused by a pathogen such as a virus, bacterium, or parasite. change of name from 'infection adverse event' to 'infectious adverse event' on 09/23/13 for a better clinical relevance, move 'infection adverse event' as an alternative term - SS WEB: http://medical-dictionary.thefreedictionary.com/infection AE severity G1 AE severity G2 AE severity G3 AE severity G4 AE severity G5